Cautious Optimism and Considerations for Health Providers and Patients: Oral Antiviral for Early Treatment of High-Risk Patients and Vaccines for Prevention of COVID-19
- 17 March 2022
- journal article
- editorial
- Published by Elsevier in The American Journal of Medicine
- Vol. 135 (7) , 808-809
- https://doi.org/10.1016/j.amjmed.2022.02.041
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Genomic surveillance to combat COVID-19: challenges and opportunitiesPublished by Elsevier ,2021
- Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USANature Human Behaviour, 2021
- Changing Patterns in the Selection of Viral Mutations among Patients Receiving Nucleoside and Nucleotide Drug Combinations Directed against Human Immunodeficiency Virus Type 1 Reverse TranscriptaseAntimicrobial Agents and Chemotherapy, 2005